Recent research by US. Breast Cancer researchers have discovered the use of Osteoporosis drugs help in controlling risk of Breast Cancer.
Patients using bisphosphonate range of drugs, including Fosamaz, Boniva and Zomita, have made a 40% reduction in risk of breast cancer.
The study involved 6,000 women, aged 20 to 69 years, half with invasive breast cancer. The women were interviewed about their bone health, history of fractures, and whether they had been diagnosed with Osteoporosis, and use of bisphosphonate drugs.
Head of Cancer Prevention Programs, Fred Hutchinson Cancer Research Center. Wisconsin, Polly Newcomb, Ph.d M.P.H. told British Journal of Cancer, the way in which these drugs may precent breast cancer is not known.
"These drugs may affect cell function and be important in cell growth and death," said Polly Newcomb. "Because we were able to account for important cofounders, these findings may reflect real benefits due to the anti-tumor mechanisms of these medications" Polly concluded. Acknowledge: medicalnewstoday.com Geoff.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment